scispace - formally typeset
L

Luis Furuya-Kanamori

Researcher at University of Queensland

Publications -  142
Citations -  2767

Luis Furuya-Kanamori is an academic researcher from University of Queensland. The author has contributed to research in topics: Medicine & Internal medicine. The author has an hindex of 21, co-authored 109 publications receiving 1687 citations. Previous affiliations of Luis Furuya-Kanamori include College of Health Sciences, Bahrain & Australian National University.

Papers
More filters
Journal ArticleDOI

A new improved graphical and quantitative method for detecting bias in meta-analysis

TL;DR: A new graphical method, the Doi plot, to visualize asymmetry and also a new measure, the LFK index, to detect and quantify asymmetry of study effects in Doi plots are proposed and demonstrated.
Journal ArticleDOI

Co-distribution and co-infection of chikungunya and dengue viruses

TL;DR: The geographic limits of chikungunya, dengue and the principal mosquito vectors for both viruses are determined to synthesise current epidemiological understanding of their co-distribution and to describe regions of co-endemicity in which lab-based diagnosis of suspected cases is of higher priority.
Journal ArticleDOI

Asymptomatic Clostridium difficile colonization: epidemiology and clinical implications

TL;DR: The role of asymptomatic C. difficile colonization in the progression to symptomatic CDI is reviewed, the epidemiology is described, the effectiveness of screening and intensive infection control practices for patients at risk of asynchronic CDI are assessed, and the implications for clinical practice are discussed.
Journal ArticleDOI

Prevalence of Differentiated Thyroid Cancer in Autopsy Studies Over Six Decades: A Meta-Analysis

TL;DR: It is confirmed that iDTC is common, but the observed increasing incidence is not mirrored by prevalence within autopsy studies and, therefore, is unlikely to reflect a true population-level increase in tumorigenesis.
Journal ArticleDOI

Comorbidities, exposure to medications, and the risk of community-acquired clostridium difficile infection: A systematic review and meta-analysis

TL;DR: Antimicrobial exposure was the strongest risk factor associated with CA-CDI, and patients with diarrhea who have inflammatory bowel disease, renal failure, hematologic cancer, or diabetes are appropriate populations for interventional studies of screening.